 Marsha Guess
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 12 | 2023 | 40 | 3.460 |
Why?
| | Urinary Incontinence | 4 | 2019 | 58 | 1.610 |
Why?
| | Bicycling | 4 | 2014 | 74 | 1.460 |
Why?
| | Pelvic Floor | 4 | 2021 | 24 | 1.430 |
Why?
| | Genitalia, Female | 6 | 2017 | 37 | 1.290 |
Why?
| | Sexual Dysfunction, Physiological | 5 | 2017 | 60 | 1.220 |
Why?
| | Postpartum Period | 2 | 2019 | 281 | 1.000 |
Why?
| | Pelvic Floor Disorders | 3 | 2022 | 10 | 0.920 |
Why?
| | Vibration | 4 | 2017 | 61 | 0.760 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2019 | 1198 | 0.670 |
Why?
| | Constipation | 1 | 2019 | 75 | 0.640 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2019 | 47 | 0.640 |
Why?
| | Ligaments | 6 | 2023 | 44 | 0.630 |
Why?
| | Physical Examination | 1 | 2019 | 222 | 0.610 |
Why?
| | Vagina | 5 | 2016 | 148 | 0.590 |
Why?
| | Electric Stimulation Therapy | 1 | 2017 | 56 | 0.560 |
Why?
| | Uterus | 5 | 2020 | 193 | 0.530 |
Why?
| | Puerperal Disorders | 1 | 2013 | 31 | 0.430 |
Why?
| | Body Mass Index | 3 | 2015 | 1971 | 0.430 |
Why?
| | Fecal Incontinence | 3 | 2022 | 74 | 0.410 |
Why?
| | Surgery, Plastic | 1 | 2012 | 25 | 0.400 |
Why?
| | Sensation | 3 | 2012 | 46 | 0.390 |
Why?
| | Pregnancy | 4 | 2019 | 5548 | 0.370 |
Why?
| | Sacrum | 4 | 2020 | 67 | 0.340 |
Why?
| | Recovery of Function | 1 | 2013 | 577 | 0.340 |
Why?
| | Female | 30 | 2023 | 59913 | 0.310 |
Why?
| | Clitoris | 2 | 2006 | 9 | 0.300 |
Why?
| | Cross-Sectional Studies | 6 | 2019 | 4435 | 0.290 |
Why?
| | Adult | 16 | 2019 | 30718 | 0.290 |
Why?
| | Young Adult | 6 | 2019 | 10470 | 0.270 |
Why?
| | Homeodomain Proteins | 4 | 2012 | 465 | 0.260 |
Why?
| | Sexual Behavior | 3 | 2017 | 440 | 0.240 |
Why?
| | Running | 1 | 2006 | 209 | 0.240 |
Why?
| | Consensus | 3 | 2022 | 532 | 0.230 |
Why?
| | Humans | 31 | 2023 | 115587 | 0.220 |
Why?
| | Middle Aged | 13 | 2020 | 26999 | 0.210 |
Why?
| | Perineum | 2 | 2012 | 27 | 0.200 |
Why?
| | Suburethral Slings | 2 | 2013 | 5 | 0.200 |
Why?
| | Pelvis | 2 | 2016 | 92 | 0.200 |
Why?
| | Delivery, Obstetric | 3 | 2015 | 119 | 0.190 |
Why?
| | Uterine Prolapse | 4 | 2009 | 14 | 0.190 |
Why?
| | Equipment Design | 2 | 2014 | 517 | 0.190 |
Why?
| | Cesarean Section | 3 | 2013 | 169 | 0.190 |
Why?
| | Receptors, Estrogen | 1 | 2023 | 372 | 0.180 |
Why?
| | Hysterectomy | 3 | 2013 | 118 | 0.180 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 4665 | 0.180 |
Why?
| | Sexual Dysfunctions, Psychological | 3 | 2012 | 31 | 0.180 |
Why?
| | Pelvic Pain | 1 | 2019 | 33 | 0.170 |
Why?
| | Health Surveys | 1 | 2019 | 446 | 0.150 |
Why?
| | Radiology | 1 | 2021 | 196 | 0.150 |
Why?
| | Orgasm | 1 | 2017 | 6 | 0.150 |
Why?
| | Prospective Studies | 4 | 2020 | 6264 | 0.140 |
Why?
| | Models, Animal | 2 | 2016 | 350 | 0.140 |
Why?
| | Logistic Models | 2 | 2019 | 1856 | 0.140 |
Why?
| | Connecticut | 1 | 2015 | 21 | 0.130 |
Why?
| | Risk Factors | 4 | 2020 | 8697 | 0.130 |
Why?
| | Surgical Mesh | 2 | 2013 | 42 | 0.120 |
Why?
| | Urinary Incontinence, Stress | 1 | 2013 | 13 | 0.110 |
Why?
| | Consumer Product Safety | 1 | 2013 | 31 | 0.110 |
Why?
| | Trial of Labor | 1 | 2013 | 14 | 0.110 |
Why?
| | Women's Health | 2 | 2006 | 271 | 0.110 |
Why?
| | China | 1 | 2013 | 163 | 0.110 |
Why?
| | Libido | 1 | 2012 | 24 | 0.110 |
Why?
| | Ovariectomy | 1 | 2012 | 117 | 0.100 |
Why?
| | Adolescent | 2 | 2019 | 17889 | 0.100 |
Why?
| | Endometrial Neoplasms | 1 | 2013 | 151 | 0.090 |
Why?
| | Pressure | 1 | 2011 | 220 | 0.090 |
Why?
| | Birth Weight | 1 | 2013 | 438 | 0.090 |
Why?
| | Rectovaginal Fistula | 1 | 2009 | 8 | 0.090 |
Why?
| | Rectal Diseases | 1 | 2009 | 17 | 0.090 |
Why?
| | Health Care Costs | 1 | 2013 | 384 | 0.090 |
Why?
| | Aged | 5 | 2015 | 19251 | 0.080 |
Why?
| | Biopsy | 1 | 2013 | 1056 | 0.080 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 340 | 0.080 |
Why?
| | Pregnancy, Ectopic | 1 | 2009 | 53 | 0.080 |
Why?
| | Abscess | 1 | 2009 | 72 | 0.080 |
Why?
| | Cicatrix | 1 | 2009 | 50 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2015 | 6417 | 0.070 |
Why?
| | Smoking | 1 | 2013 | 1457 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2009 | 449 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 744 | 0.060 |
Why?
| | Genital Diseases, Female | 1 | 2005 | 27 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 2907 | 0.060 |
Why?
| | Urologic Surgical Procedures | 1 | 2005 | 94 | 0.060 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2004 | 27 | 0.060 |
Why?
| | Follow-Up Studies | 1 | 2013 | 4440 | 0.060 |
Why?
| | Prostheses and Implants | 1 | 2005 | 140 | 0.060 |
Why?
| | Fibroblasts | 1 | 2009 | 839 | 0.060 |
Why?
| | Ultrasonography | 2 | 2021 | 641 | 0.060 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 35 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2006 | 1440 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2013 | 5077 | 0.050 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 120 | 0.050 |
Why?
| | Receptors, Androgen | 1 | 2023 | 132 | 0.050 |
Why?
| | Menopause | 1 | 2005 | 262 | 0.050 |
Why?
| | Public Opinion | 1 | 2022 | 59 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2009 | 2194 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2012 | 2161 | 0.050 |
Why?
| | Radiography, Abdominal | 1 | 2021 | 33 | 0.050 |
Why?
| | Estrogens | 1 | 2023 | 315 | 0.050 |
Why?
| | Child | 1 | 2019 | 18488 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2020 | 3022 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 4773 | 0.040 |
Why?
| | NIH 3T3 Cells | 2 | 2009 | 137 | 0.040 |
Why?
| | Research Design | 1 | 2004 | 946 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2023 | 695 | 0.040 |
Why?
| | Connective Tissue | 1 | 2016 | 36 | 0.030 |
Why?
| | Mice | 4 | 2016 | 15052 | 0.030 |
Why?
| | Muscle, Smooth | 1 | 2016 | 150 | 0.030 |
Why?
| | Sensory Thresholds | 2 | 2005 | 28 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1631 | 0.030 |
Why?
| | Device Approval | 1 | 2013 | 21 | 0.030 |
Why?
| | Decision Trees | 1 | 2013 | 81 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2578 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 2829 | 0.030 |
Why?
| | Gelatinases | 1 | 2012 | 6 | 0.030 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2012 | 10 | 0.030 |
Why?
| | Enzyme Precursors | 1 | 2012 | 15 | 0.030 |
Why?
| | Collagen Type III | 1 | 2012 | 18 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 23 | 0.030 |
Why?
| | Nervous System Diseases | 2 | 2005 | 253 | 0.030 |
Why?
| | Collagen Type I | 1 | 2012 | 110 | 0.020 |
Why?
| | United States | 2 | 2021 | 12295 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2013 | 538 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 302 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2262 | 0.020 |
Why?
| | Cohort Studies | 1 | 2020 | 4944 | 0.020 |
Why?
| | Pilot Projects | 2 | 2005 | 1377 | 0.020 |
Why?
| | Animals | 4 | 2016 | 32102 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2013 | 548 | 0.020 |
Why?
| | Rectocele | 1 | 2009 | 3 | 0.020 |
Why?
| | Ischium | 1 | 2009 | 5 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3069 | 0.020 |
Why?
| | Uterine Artery Embolization | 1 | 2009 | 6 | 0.020 |
Why?
| | Societies, Medical | 1 | 2013 | 684 | 0.020 |
Why?
| | Abortifacient Agents, Nonsteroidal | 1 | 2009 | 19 | 0.020 |
Why?
| | Uterine Hemorrhage | 1 | 2009 | 35 | 0.020 |
Why?
| | Chorionic Gonadotropin | 1 | 2009 | 78 | 0.020 |
Why?
| | Self Report | 1 | 2012 | 698 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1718 | 0.020 |
Why?
| | Prolapse | 1 | 2008 | 5 | 0.020 |
Why?
| | Methotrexate | 1 | 2009 | 228 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2008 | 56 | 0.020 |
Why?
| | Rats | 1 | 2016 | 5034 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 117 | 0.020 |
Why?
| | Polypropylenes | 1 | 2005 | 16 | 0.020 |
Why?
| | Collagen | 1 | 2008 | 415 | 0.020 |
Why?
| | Anus Diseases | 1 | 2005 | 7 | 0.020 |
Why?
| | Touch | 1 | 2005 | 30 | 0.020 |
Why?
| | Nervous System | 1 | 2005 | 63 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1180 | 0.020 |
Why?
| | Anal Canal | 1 | 2005 | 83 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1642 | 0.010 |
Why?
| | International Cooperation | 1 | 2004 | 174 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2013 | 12608 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 3914 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2008 | 2574 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2004 | 684 | 0.010 |
Why?
| | Comorbidity | 1 | 2005 | 1473 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2005 | 906 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1405 | 0.010 |
Why?
| | Male | 1 | 2013 | 55949 | 0.000 |
Why?
|
|
Guess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|